Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Mycophenolate mofetil in multiple sclerosis.
MS Research Roundup: November 5, 2014
Rapidly progressive cerebellar ataxia in West Wales.
'Strikingly' Lower Familial Risk of MS Seen
MS Patient, Ph.D.: Hoping New Biomarkers Make MS More Predictable
Keystone Symposia Conference: Autoimmunity and Tolerance
Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Nominations Open for Dystel Prize for MS Research
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.
Teriflunomide Gets High Marks in Yet Another Phase 3 Trial
Precision medicine in chronic disease management: The MS BioScreen.
ECTRIMS 2013 Day 4
CellCept Drug Details
Biogen Idec and Genentech Announce Restructuring of anti-CD20 Collaboration Agreement
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.
Episode 68 with Dr. Philip De Jager on the state of MS genetics
5th Axon Degeneration Meeting
Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold
Episode 64 with Dr. Helen Tremlett on pediatric MS and the gut microbiome
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
Unusual association of Arnold-Chiari malformation and vitamin B12 deficiency.

Pages

« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By